Enlarged Board of Appeal rules on double patenting

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Enlarged Board of Appeal rules on double patenting

Sponsored by

maiwald-logo-cropped.PNG
butterflies-1127666-1280-1.jpg

Annelie Wünsche and Stefanie Parchmann of Maiwald discuss double patenting before the EPO

On June 22 2021, the Enlarged Board of Appeal of the European Patent Office issued decision G 4/19 (Double patenting), in which it held that a European patent (EP) application can be refused if it claims the same subject matter as a granted European patent (i.e. not just a co-pending EP application) which has been granted to the same applicant and has the same effective date. 

The application can be refused irrespective of whether it (a) was filed on the same date as, or (b) is a parent application or a divisional application of, or (c) claims the same priority as the European patent already granted.

In other words: if an applicant already achieved grant of an EP patent on a certain subject matter, the Examining Division will deny grant to claims on the ‘same’ subject matter in later examination proceedings pertaining to an application having the same ‘effective date’ as the granted patent.

This even applies if the EP patent that was granted earlier is the priority application of the later-examined application. The advantage of a longer term of protection (due to the later filing date) that is thus lost for the applicant is no justification for allowing double patenting.

The Enlarged Board of Appeal relied on Article 125 EPC, which stipulates that “in the absence of procedural provisions in this Convention, the European Patent Office shall take into account the principles of procedural law generally recognised in the Contracting States”.

Two pieces of the puzzle, however, were deliberately not examined by the Enlarged Board of Appeal. First, even though the referring Board asked for clarification, the concept of ‘same subject matter’ was not addressed (does overlap also count?). Second, the question whether the rules on double patenting will also have to be applied in opposition proceedings remained unanswered.

But we notice that a distinction between ‘double protection’ (claims with overlapping scope) and ‘double patenting’ was made in the Reasons, and we are therefore quite confident that the prohibition of double patenting will remain a prohibition of double patenting in a narrow sense, limited to claims on exactly the ‘same’ invention. Overlapping claims should, therefore, remain admissible.

Thus, tailoring the claims of the later application to a merely overlapping claim scope might still provide the possibility to get the later application granted. It remains to be seen whether filing a request for revocation of the earlier patent will be allowed as a means to address a double patenting situation. 

We are also curious to see whether double patenting rules will now be applied more often in opposition proceedings; at present, applying them is within the discretion of an opposition division. 

 

Annelie Wünsche

Partner, Maiwald 

E: wuensche@maiwald.eu

 

Stefanie Parchmann

Partner, Maiwald 

E: parchmann@maiwald.eu

 

 

more from across site and SHARED ros bottom lb

More from across our site

Morgan Lewis adds three partners with technical depth, reinforcing the firm’s strategy to bridge legal and tech expertise in patent litigation
The firm posted a 13% increase in profit as well as a rise in overall revenue
Catherine Lee, one of Managing IP’s Top 250 Women in IP 2025, discusses her ‘soft’ approach to leadership and why building a community at work is important
Transactions specialists at Paul Weiss are advising on the high-profile split of Kraft Heinz into two companies, while Skadden is also involved in the deal
Youngmin Park joins us for our ‘Five minutes with’ series to discuss learning languages, moonlighting as a drummer, and why late is better than never
The record-breaking $1.5 billion settlement between the AI company and book authors may not lead to rapid resolution of other cases, say copyright lawyers
Leaders at two Brazilian law firms outline strategies to adjust to trademark fee changes at Brazil's IP office while urging clients to apply before September 20
Former in-house counsel Andriana Shultz Daly has returned to the firm with client-side insight and courtroom skills to build the firm’s life sciences practice
The LMG Life Sciences Awards announces the 2025 winners for the 13th annual awards!
News of AI company Cerence accusing Apple of patent infringement and a hiring update from Lewis Silkin were also among the top talking points
Gift this article